| Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: comparing survival outcomes in adenocarcinoma and squamous cell carcinoma S Abel, S Hasan, R White, L Schumacher, G Finley, A Colonias, ... Lung Cancer 128, 127-133, 2019 | 33 | 2019 |
| Anal adenocarcinoma: treatment outcomes and trends in a rare disease entity RE Wegner, RJ White, S Hasan, M Raj, D Monga, G Finley, AV Kirichenko, ... Cancer Medicine 8 (8), 3855-3863, 2019 | 21 | 2019 |
| Time to adjuvant systemic therapy following pancreatic cancer resection and effect on outcome RJ White, S Hasan, D Monga, G Finley, M Islam, S Schiffman, HK Williams, ... Pancreas 48 (8), 1086-1091, 2019 | 20 | 2019 |
| Practice patterns and outcomes following radiation dose de‐escalation for oropharyngeal cancer R White, S Abel, S Hasan, V Verma, L Greenberg, A Colonias, ... The Laryngoscope 130 (4), E171-E176, 2020 | 15 | 2020 |
| Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysis RE Wegner, S Abel, RJ White, ZD Horne, S Hasan, AV Kirichenko Radiation Oncology Journal 36 (4), 276, 2018 | 12 | 2018 |
| Melanoma brain metastases: is it time to eliminate radiotherapy? RJ White, S Abel, ZD Horne, J Lee, H Edington, L Greenberg, H Younes, ... Journal of Neuro-Oncology 149, 27-33, 2020 | 11 | 2020 |
| Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report S Hasan, R White, P Renz, S Abel, Z Otaibi, D Monga, A Colonias, ... Radiotherapy and Oncology 132, 23-26, 2019 | 9 | 2019 |
| Time from stereotactic body radiotherapy to immunotherapy as a predictor for outcome in metastatic non small cell lung cancer. RE Wegner, S Abel, S Hasan, R White, GG Finley, D Monga, A Colonias, ... Journal of Clinical Oncology 37 (15_suppl), 9024-9024, 2019 | 8 | 2019 |
| Time from stereotactic radiotherapy to immunotherapy is a predictor for outcome in stage IV non-small cell lung cancer RE Wegner, S Abel, S Hasan, RJ White, G Finley, D Monga, A Colonias, ... Journal of Immunological Sciences 3 (2), 2019 | 5 | 2019 |
| Predictors of chemotherapy and its effects in early stage squamous cell carcinoma of the larynx TT Jayakrishnan, RJ White, L Greenberg, A Colonias, RE Wegner Laryngoscope Investigative Otolaryngology 5 (3), 445-452, 2020 | 4 | 2020 |
| BRAF V600E mutation in multiple primary malignancies: a hairy affair R White, Z Otaibi, R Rao, G Finley Cureus 10 (11), 2018 | 4 | 2018 |
| Bilateral adrenal haemorrhage in antiphospholipid syndrome and a short review of the literature AS Cherico, RJ White, D Shah, R Bhagavatula BMJ Case Reports CP 15 (10), e251199, 2022 | 2 | 2022 |
| Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma RE Wegner, S Abel, S Hasan, RJ White, M Raj, D Monga, G Finley, ... American Journal of Clinical Oncology 42 (6), 519-526, 2019 | 2 | 2019 |
| Inpatient outcomes of blinatumomab use: A national inpatient sample analysis. V Bakalov, A Tang, AM Helfand, P Kancharla, R White, A Khattab, ... Journal of Clinical Oncology 40 (16_suppl), e19021-e19021, 2022 | | 2022 |
| A national inpatient sample analysis for CAR-T cell therapy administration. V Bakalov, A Tang, AM Helfand, P Kancharla, R White, A Khattab, ... Journal of Clinical Oncology 40 (16_suppl), e19501-e19501, 2022 | | 2022 |
| The rate of venous thromboembolism in patients with non-small cell lung cancer treated with chemotherapy or check point inhibitors. S Singu, V Bakalov, AM Helfand, P Kancharla, R White, A Khattab, ... Journal of Clinical Oncology 40 (16_suppl), e21053-e21053, 2022 | | 2022 |
| Assessment of compliance with national guidelines in genetic testing and tumor profiling in patients diagnosed with pancreatic adenocarcinoma: A retrospective review. K Shankar, S Srinivasamaharaj, Y Samhouri, S Rizwan, D Shah, J Liu, ... Journal of Clinical Oncology 39 (15_suppl), e16260-e16260, 2021 | | 2021 |
| Immunotherapy and Melanoma Brain Metastases: Is It Time to Omit Radiation? R White, S Abel, S Karlovits, L Greenberg, C Hilton, H Younes, J Lee, ... Cureus Journal of Medical Science 12 (4), 2020 | | 2020 |
| EPID-18. NATIONAL TRENDS IN THE USE OF TARGETED AND IMMUNOTHERAPY IN THE UP FRONT MANAGEMENT OF GLIOBLASTOMA R Wegner, R White, S Abel, A Yu, L Xu, S Karlovits, T Ranjan Neuro-oncology 21 (Suppl 6), vi78, 2019 | | 2019 |
| Influence of post-resection time to chemotherapy in pancreatic adenocarcinoma on overall survival. S Abel, R White, S Schiffman, K Williams, S Thakkar, DK Monga, ... Journal of Clinical Oncology 37 (15_suppl), e15791-e15791, 2019 | | 2019 |
